P379: PONATINIB AND BLINATUMOMAB IN RELAPSED/REFRACTORY PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR CHRONIC MYELOID LEUKEMIA IN LYMPHOID BLAST PHASE: SUBGROUP ANALYSIS FROM A PHASE II TRIAL

• Fadi Haddad,
• Elias Jabbour,
• Marianne Zoghbi,
• Nicholas Short,
• Cedric Nasnas,
• Lewis Nasr,
• Walid Macaron,
• Nitin Jain,
• Xuelin Huang,
• Guillermo Montalban-Bravo,
• Tapan Kadia,
• Naval Daver,
• Kelly Chien,
• Yesid Alvarado,
• Guillermo Garcia-Manero,
• Ghayas Issa,
• Monica Kwari,
• Ricardo Delumpa,
• Ejiroghene Mayor,
• Wuliamatu Deen,
• Jennifer Thankachan,
• Christopher Loiselle,
• Juan Rivera,
• Anna Milton,
• Lourdes Waller,
• Glenda Banks,
• Rebecca Garris,
• Farhad Ravandi,
• Hagop Kantarjian

Affiliations

Fadi Haddad

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Elias Jabbour

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Marianne Zoghbi

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Nicholas Short

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Cedric Nasnas

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Lewis Nasr

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Walid Macaron

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Nitin Jain

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Xuelin Huang

2 The University of Texas MD Anderson Cancer Center, Biostatistics, Houston, United States

Guillermo Montalban-Bravo

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Tapan Kadia

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Naval Daver

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Kelly Chien

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Yesid Alvarado

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Guillermo Garcia-Manero

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Ghayas Issa

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Monica Kwari

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Ricardo Delumpa

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Ejiroghene Mayor

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Wuliamatu Deen

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Jennifer Thankachan

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Christopher Loiselle

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Juan Rivera

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Anna Milton

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Lourdes Waller

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Glenda Banks

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Rebecca Garris

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Farhad Ravandi

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Hagop Kantarjian

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States